| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.056 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |